In-vitro bactericidal synergism of rifampicin and trimethoprim and implications for treatment of carriers of Haemophilus influenzae.
D002353:Carrier State / Q000188:drug therapy*; D004357:Drug Synergism; D006192:Haemophilus Infections / Q000188:drug therapy*; D006193:Haemophilus influenzae / Q000187:drug effects*; D006801:Humans; D007700:Kinetics; D008826:Microbial Sensitivity Tests; D012293:Rifampin / Q000494:pharmacology*; D014295:Trimethoprim / Q000494:pharmacology*
D014295:Trimethoprim; D012293:Rifampin